Schwelm Hannes M, Grumann Christina, Auwärter Volker, Neukamm Merja A
Institute of Forensic Medicine, Forensic Toxicology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Hermann Staudinger Graduate School, University of Freiburg, Freiburg, Germany.
Drug Test Anal. 2020 Sep;12(9):1354-1365. doi: 10.1002/dta.2886. Epub 2020 Jul 23.
Interpretation of amphetamine-type stimulant (ATS) findings in urine samples can be challenging without chiral information. We present a sensitive enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantification of (R)-amphetamine, (S)-amphetamine, (R)-methamphetamine, (S)-methamphetamine, (1R,2R)-pseudoephedrine, (1S,2S)-pseudoephedrine, (1R,2S)-ephedrine, (1S,2R)-ephedrine, (1R,2S)-norephedrine, (1S,2R)-norephedrine, (R)-cathinone, (S)-cathinone, and (1S,2S)-norpseudoephedrine (cathine) in urine. The method was successfully applied to more than 100 authentic urine samples from forensic casework. In addition, samples from a controlled self-administration of (1S,2S)-pseudoephedrine (Rinoral, 1200 mg within 6 days) were analyzed. The results strengthen the hypothesis that (1R,2S)-norephedrine is a minor metabolite of amphetamine and methamphetamine. We suggest cathine and (1S,2R)-norephedrine as minor metabolites of amphetamine racemate in humans. Small methamphetamine concentrations detected in samples with high concentrations of amphetamine could result from a metabolic formation by methylation of amphetamine although in samples with an (R)/(S) ratio for methamphetamine < 1 an additional (previous) (S)-methamphetamine consumption seems likely. Our data suggest that even amphetamine concentrations exceeding methamphetamine concentrations in urine can be caused by the biotransformation of methamphetamine to amphetamine as long as no (R)-amphetamine is detected. However, without chiral information, such findings might be (falsely) assumed as a co-consumption of both substances. Cathinone enantiomers detected in urine samples with high amphetamine concentrations can be interpreted as metabolites of amphetamine. In addition, the results of the self-administration study revealed that both cathinone enantiomers are minor metabolites of (1S,2S)-pseudoephedrine, which is the active ingredient of various medicines used for cold. The enantioselective analysis is a powerful tool to avoid the misinterpretation of ATS findings in urine samples.
在缺乏手性信息的情况下,对尿液样本中苯丙胺类兴奋剂(ATS)检测结果的解读可能具有挑战性。我们提出了一种灵敏的对映体选择性高效液相色谱 - 串联质谱法,用于定量尿液中的(R)-苯丙胺、(S)-苯丙胺、(R)-甲基苯丙胺、(S)-甲基苯丙胺、(1R,2R)-伪麻黄碱、(1S,2S)-伪麻黄碱、(1R,2S)-麻黄碱、(1S,2R)-麻黄碱、(1R,2S)-去甲麻黄碱、(1S,2R)-去甲麻黄碱、(R)-卡西酮、(S)-卡西酮和(1S,2S)-去甲伪麻黄碱(去甲伪麻黄碱)。该方法已成功应用于100多个法医案件的真实尿液样本。此外,还分析了(1S,2S)-伪麻黄碱(瑞诺拉,6天内服用1200毫克)的对照自我给药样本。结果强化了以下假设:(1R,2S)-去甲麻黄碱是苯丙胺和甲基苯丙胺的次要代谢产物。我们认为去甲伪麻黄碱和(1S,2R)-去甲麻黄碱是人体中苯丙胺外消旋体的次要代谢产物。在高浓度苯丙胺的样本中检测到的低浓度甲基苯丙胺,可能是由苯丙胺甲基化的代谢形成所致,不过在甲基苯丙胺(R)/(S)比值<1的样本中,似乎还可能存在额外的(之前的)(S)-甲基苯丙胺摄入。我们的数据表明,只要未检测到(R)-苯丙胺,尿液中即使苯丙胺浓度超过甲基苯丙胺浓度,也可能是由甲基苯丙胺生物转化为苯丙胺引起的。然而,在缺乏手性信息的情况下,此类结果可能会(错误地)被认为是两种物质的共同摄入。在高浓度苯丙胺的尿液样本中检测到的卡西酮对映体可被解释为苯丙胺的代谢产物。此外,自我给药研究结果表明,两种卡西酮对映体都是(1S,2S)-伪麻黄碱的次要代谢产物,(1S,2S)-伪麻黄碱是用于治疗感冒的各种药物的活性成分。对映体选择性分析是避免对尿液样本中ATS检测结果产生错误解读的有力工具。